Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Traphaco

Market Cap 3,229B 123M 107M 99.15M 92.54M 174M 11.59B 175M 1.18B 458M 5.7B 461M 451M 19.8B P/E 2024
15.7x
P/E 2025 14.3x
Enterprise Value 2,660B 101M 88.29M 81.67M 76.23M 143M 9.55B 144M 970M 378M 4.69B 379M 371M 16.31B EV / Sales 2024
1.16x
EV / Sales 2025 0.96x
Free-Float
55.44%
Yield 2024
5.1%
Yield 2025 -
04-29 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-23 Traphaco Joint Stock Company Receives Large Enterprise Tax Department Decision on Tax Inspection and Administrative Penalties for Fiscal Years 2023 and 2024 CI
01-30 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
12-26 Traphaco Joint Stock Company Announces First Cash Dividend Payment in 2025, Payable on January 28, 2026 CI
11-19 Traphaco Joint Stock Company Announces Change in Business Registration Certificate Issued by Hanoi Department of Finance CI
11-10 Traphaco Joint Stock Company Announces Chief Executive Officer Changes, Effective November 10, 2025 CI
11-06 Traphaco Joint Stock Company Announces Resignation of Ms. Nguyen Thi Giang as Member of the Board of Supervisors CI
30/10/25 Traphaco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
10/09/25 Traphaco Joint Stock Company Announces Dissolution of Branches CI
30/07/25 Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
30/04/25 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
03/02/25 Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
16/12/24 Traphaco Joint Stock Company Approves First Interim Dividend for 2024, Payable on January 24, 2025 CI
1 week+1.30%
Current month-2.62%
1 month-1.39%
3 months+14.90%
6 months+1.83%
Current year+3.87%
1 week 77,000
Extreme 77000
79,000
1 month 76,000
Extreme 76000
81,000
Current year 65,000
Extreme 65000
81,000
1 year 63,000
Extreme 63000
81,000
3 years 63,000
Extreme 63000
93,400
5 years 63,000
Extreme 63000
105,000
10 years 43,100
Extreme 43100
142,000
Manager TitleAgeSince
Chief Executive Officer 61 17/09/2012
Corporate Secretary - 30/03/2018
Comptroller/Controller/Auditor 44 01/01/1994
Director TitleAgeSince
Chairman 70 18/10/2010
Director/Board Member 61 01/01/1994
Director/Board Member 48 30/03/2016
Date Insider Type Main position Quantity % Market Cap.
15/04/25Buy 33,264 0.0802%
05/10/23Sell

Executive/Senior Manager

7,200 0.0174%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.30%+13.23%-16.60% 123M
+0.32%-2.41%+44.49%+140.80% 983B
+1.27%-1.85%+54.41%+39.65% 557B
+6.25%+3.80%+24.13%+67.39% 406B
+1.63%-1.93%+23.33%+16.35% 314B
+1.96%+1.97%+29.99%+18.59% 273B
+1.64%+2.14%+28.59%+34.81% 272B
+1.95%+9.01%-32.20%-43.85% 203B
+2.11%-1.66%+19.14%+50.10% 186B
+0.90%+0.46%+15.09%+59.86% 155B
Average +1.80%-0.92%+22.02%+36.71% 335.05B
Weighted average by Cap. +1.78%-2.22%+31.79%+64.83%

Financials

2024 2025
Net sales 2,347B 89.17M 77.92M 72.08M 67.27M 126M 8.43B 127M 856M 333M 4.14B 335M 328M 14.39B 2,657B 101M 88.21M 81.59M 76.16M 143M 9.54B 144M 970M 377M 4.69B 379M 371M 16.29B
Net income 239B 9.08M 7.93M 7.34M 6.85M 12.86M 858M 12.95M 87.22M 33.93M 422M 34.09M 33.35M 1.47B 250B 9.48M 8.29M 7.67M 7.16M 13.43M 896M 13.53M 91.1M 35.45M 441M 35.61M 34.84M 1.53B
Net Debt -540B -20.53M -17.94M -16.6M -15.49M -29.08M -1.94B -29.29M -197M -76.73M -954M -77.09M -75.42M -3.31B -569B -21.63M -18.9M -17.48M -16.32M -30.64M -2.04B -30.86M -208M -80.84M -1.01B -81.22M -79.45M -3.49B
Logo Traphaco
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Employees
1,546
Date Price Change Volume
22/06/26 ₫77,900.00 0.00% 201
19/06/26 ₫77,900.00 -0.13% 1,411
18/06/26 ₫78,000.00 +0.26% 3,831
17/06/26 ₫77,800.00 -1.02% 1,261
16/06/26 ₫78,600.00 +2.21% 335

Net sales - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!